Use of Oral Anticoagulation and Diabetes Do Not Inhibit the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes

Patients suffering from tissue ischemia, who would greatly benefit from angiogenesis-promoting therapies such as hypoxia preconditioned blood-derived secretomes commonly receive oral anticoagulation (OA) and/or have diabetes mellitus (DM). In this study, we investigated the effect of OA administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Moog, Philipp, Jensch, Maryna, Hughes, Jessica, Salgin, Burak, Dornseifer, Ulf, Machens, Hans-Günther, Schilling, Arndt F., Hadjipanayi, Ektoras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459715/
https://www.ncbi.nlm.nih.gov/pubmed/32796694
http://dx.doi.org/10.3390/biomedicines8080283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459715/
https://www.ncbi.nlm.nih.gov/pubmed/32796694
http://dx.doi.org/10.3390/biomedicines8080283

Ejemplares similares